Navigation Links
SuperNova Diagnostics® to Present at AdvaMed 2011: The Medtech Conference in Washington, D.C.
Date:9/22/2011

GERMANTOWN, Md., Sept. 22, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, today announced that Neil J. Campbell, president and CEO, will be presenting at AdvaMed 2011: The Medtech Conference in Washington, D.C. on September 27, 2011 at 11:00 a.m. in room 204A of the Walter E. Washington Convention Center in Washington, D.C.  

The presentation will include an overview of SuperNova's proprietary point-of-care (POC) and point-of-use (POU) diagnostic technology targeting four industry sectors: human health, animal health, industrial and biodefense/biosecurity.

"AdvaMed 2011 is the premier event for investors and leaders in the medical technology industry, and thus is an ideal opportunity for SuperNova to showcase its game-changing, disruptive technology and 'lab-in-the-palm-of-your-hand' diagnostic system," said Mr. Campbell.  "With our proprietary AmpCrystal® platform, which provides an array of diagnostic capabilities from patient treatment to pathogen detection, SuperNova has the potential to seize the still largely untapped multi-billion dollar point-of-care and point-of-use diagnostic market."

About SuperNova Diagnostics®, Inc.

SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications.  A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements.  SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® — Putting the Laboratory in the Palm of Your Hand®.  For additional information, please visit www.supernovadiagnostics.com.

Contacts:
Tiberend Strategic Advisors, Inc.
Jason Rando / Madeleine Desmond
(212) 827-0020
jrando@tiberend.com / mdesmond@tiberend.com


'/>"/>
SOURCE SuperNova Diagnostics(R), Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SuperNova Diagnostics® Announces Agreement with KSB Diagnostics of China to Commercialise Neopterin Diagnostics
2. SuperNova Diagnostics® Selected to Present at Launch: Silicon Valley 2011
3. Quest Diagnostics® Care360™ EHR Receives ONC-ATCB 2011/2012 Certification
4. InterMune to Present at Canaccord Adams Conference
5. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
6. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
7. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
8. Bionovo to Present at Canaccord Adams Global Growth Conference
9. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
10. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
11. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... , ... September 21, 2017 , ... ... company, who enable the world’s most progressive pharma and biotech organizations to do ... at top pharma and biotech events in Q4. , DrugDev will demonstrate DrugDev ...
(Date:9/21/2017)... ... 2017 , ... Lajollacooks4u welcomed the San Diego chapter of Les Dames d’Escoffier ... professional women with high achievement in the fields of food, fine beverage and hospitality, ... members began with an olive oil tasting to whet their palettes and then rolled ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... today that it has appointed Vishwas Paralkar to the role of chief scientific ... targeting technology. He will report to Cybrexa’s president and CEO, Per Hellsund. , ...
(Date:9/20/2017)... ... 2017 , ... Proscia Inc. , a data solutions ... whole slide imaging solutions, are hosting a pre-conference workshop at the Digital ... Best-in-Class Strategy for Digital Pathology,” will feature Proscia CEO, David West Jr., and ...
Breaking Biology Technology:
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
Breaking Biology News(10 mins):